Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will be well represented at the 2018 American Society of Clinical Oncology (ASCO) meeting June 1- 5 in Chicago, as several physicians and researchers are scheduled
At the Plenary Session on Sunday, June 3, Gilberto Lopes, M.D., M.B.A., associate director of Global Oncology at Sylvester, will present the abstract on the Phase III KEYNOTE-42 study, comparing the immunotherapy pembrolizumab to platinum-based chemotherapy as first-line therapy in a subset of lung cancer patients.












